BioPhorum acquires training organisation Brookwood Global.

BioPhorum, the global organization accelerating collaboration between biopharmaceutical and medical device industry leaders, has today announced the acquisition of Brookwood Global, a UK-based provider of training and educational content for professionals operating in the field of clinical research.BioPhorum has been at the heart of the biopharmaceutical industry for more than 15 years. Trusted by leaders from across the industry, it enables them to work together in non-competitive, confidential settings to seek out solutions for the benefit of all. Its members are united by their drive to save and improve patient outcomes and they recognize BioPhorum as the engine room for change in their industry.Brookwood Global is a privately owned organization, based in the UK, that has been delivering professional development solutions in the fields of clinical research and drug safety since 1996. Brookwood has trained more than 100,000 clinical research staff from c. 120 countries worldwide.On announcing the acquisition, Deborah Kobewka, BioPhorum CEO, said “We are delighted to be joining forces with the team at Brookwood. Their expertise in digital training integrates perfectly with our advanced knowledge of the biopharmaceutical and life sciences industries, creating opportunities for diversification and growth for both organizations.“The relationship also provides BioPhorum with the opportunity to expand our unique proposition into adjacent and connected segments of the pharmaceutical process/value chain, and to develop new services that will help our members derive maximum value from their relationship with us